Ссылки [1] Яременко О.Б. Глюкокортикоиды в ревматологии: современная номенклатура дозовых режимов и рациональное применение // Украинский Ревматологический Журнал 2002;9:20-26 www.rheumatology.kiev.ua/wp/wp-c…/183.pdf [2] Buttgereit, F. Views on glucocorticoid therapy in rheumatology: the age of convergence. Nat Rev Rheumatol 16, 239–246 (2020). https://doi.org/10.1038/s41584-020-0370-z [3] 2016 updated EULAR evidence-based recommendations for the management of gout https://ard.bmj.com/content/76/1/29 [4] 2020 American College of Rheumatology Guideline for the Manage www.rheumatology.org/Portals…2020.pdf [5] Corticosteroid or Nonsteroidal Antiinflammatory Drugs for the Treatment of Acute Gout: A Systematic Review of Randomized Controlled Trials. Christy Amanda Billy, Ricky Tanujaya Lim, Marinella Ruospo, Suetonia C. Palmer and Giovanni F.M. Strippoli. The Journal of Rheumatology August 2017, jrheum.170137; DOI: https://doi.org/10.3899/jrheum.170137 [6] Xu, L., Liu, S., Guan, M., & Xue, Y. (2016). Comparison of Prednisolone, Etoricoxib, and Indomethacin in Treatment of Acute Gouty Arthritis: An Open-Label, Randomized, Controlled Trial. Medical science monitor : international medical journal of experimental and clinical research, 22, 810–817. https://doi.org/10.12659/msm.895749 [7] Zhang, Y. K., Yang, H., Zhang, J. Y., Song, L. J., & Fan, Y. C. (2014). Comparison of intramuscular compound betamethasone and oral diclofenac sodium in the treatment of acute attacks of gout. International journal of clinical practice, 68(5), 633–638. https://doi.org/10.1111/ijcp.12359